Friday, August 03, 2012

Bristol Exec Charged With Insider Trading - Aug. 3, 2012

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Friday, August 03, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Latin American Ethics and Compliance Network
Cosponsored by Pharmaceutical Compliance Forum
Media Partners: Life Science Compliance and RX Compliance Report

October 2 - 4, 2012
Hilton Sao Paulo Morumbi
Sao Paulo, Brazil

Please click here for more information.
HeadHtml
•   Bristol-Myers Squibb Company (BMY) Exec Charged With Insider Trading More...
•   Johnson & Johnson (JNJ) Reveals Settlement of Lawsuits More...
More Legal News
HeadHtml
•   Biotech Start-Up Atterocor Raises $16 Million Series A More...

More Startup News
HeadHtml
•   Burrill & Company Touts New Life Sciences Fund Worth $505 Million More...
•   Elusys Therapeutics, Inc. Gets $50.2 Million to Advance Investigational Anthrax Treatment More...

More Finance News
HeadHtml
•   Recordati S.p.A Buys Poland's Farma-Projekt for 17.3 Million Euros More...
•   Sun Pharmaceutical Industries Ltd of India Said to Eye Germany's STADA Arzneimittel AG (STAGn.DE) More...
•   Opko Health, Inc. Announces Acquisition of Growing European Healthcare Company More...
More Mergers and Acquisitions News
HeadHtml
•   Gilead Sciences, Inc. (GILD) Inks Deals With 3 Indian Companies Including Ranbaxy Laboratories (RANBAXY.BO) for Low-Cost HIV Drug More...
•   XOMA (US) LLC (XOMA) Announces Manufacturing Agreement With Les Laboratoires Servier and Boehringer Mannheim Corporation More...
•   Mylan Inc. (MYL) Signs Agreement with Gilead Sciences, Inc. (GILD) to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine More...
•   Waters Corporation (WAT) and Nonlinear Dynamics to Co-Develop Next Generation Research Solutions for Large-Scale, Complex Data Sets More...
•   Marina Biotech, Inc. Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry More...
More Alliances News

•   Biostem U.S. Corporation (BOSM) Scientific and Medical Board of Advisors Member Appointed Chief of Cardiothoracic Surgery at St. Francis Hospital More...
•   Celltex Therapeutics Corporation Expands Laboratory Operations and Adds Depth to Its Management Team More...
•   Inspiration Biopharmaceuticals Expands Industry Expertise With Five New Executive Hires More...
•   Immunovative Inc. Announces the Appointment of Dr. Zivile Katiliene as Director of Regulatory Affairs and Clinical Operations for Immunovative Therapies, Ltd. More...
•   ZYTO Corp. Announces Expansion of Scientific Advisory Board More...
More Personnel News
Tower: Facebook
Events

The 4th Annual Personalized Medicine
September 12 - 13, 2012
Boston, MA
Event Website

Arrowhead's 4th Annual Personalized Medicine Conference will tackle the issues driving as well as restraining the clinical delivery of personalized medicine, including coding and reimbursement, the economics of personalized medicine and medicare policy.

• CLINICAL delivery of personalized medicine
• WHOLE GENOME SEQUENCING in practice of medicine
• CODING & reimbursement for companion diagnostics
• CLINICAL APPLICATION of genetic testing
• ECONOMICS of personalized medicine
• MEDICARE coverage for companion diagnostics
• MARKET ACCESS challenges for companion diagnostics

Please click here for more information.

The Life Sciences Report: Special Report Reveals Biotech Stock Drivers: Michael Hay
By: George S. Mack of The Life Sciences Report

Certain predictable dates and events bring profound effects to bear on biotech stocks. Michael Hay, vice president of Sagient Research Systems, successfully applies the art and science of important catalysts to predict when biotech stocks will move up or down. In this exclusive interview with The Life Sciences Report, Hay discusses his strategy and names companies that will produce meaningful gains for investors. More...
 
HeadHtml
•   Teva Pharmaceutical Industries Limited (TEVA) Second-Quarter Profit Climbs 50% on Stronger US Sales More...
•   Aastrom Biosciences, Inc. (ASTM) to Host Second Quarter 2012 Investor Call on August 7, 2012 More...
•   Bioanalytical Systems, Inc. (BASI) to Release Third Quarter Results Tuesday, August 14, 2012; Conference Call & Webcast Set For 11:00 a.m. EDT More...
•   Cornerstone Therapeutics Inc. to Host Second Quarter 2012 Conference Call More...
•   Cadence Pharmaceuticals, Inc. Reports Second Quarter 2012 Financial Results More...
More Earnings Report News
Real Estate



R&D/Laboratory Facility For Sublease
7 Graphics Drive
Ewing, New Jersey U.S.A

Building Size: 72,300 SF
Available Area: 18,577 RSF
Term: May 2017

More Real Estate Listings
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Feature

Hot Company

Intrexon Corporation
20358 Seneca Meadow Parkway
Germantown, Maryland 20876 U.S.A.
Phone: 301-556-9900 Fax: 301-556-9901

Founded in 1998, Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive capabilities to rapidly design and produce novel and enhanced biological products and processes across multiple industry sectors, including: human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science.

More Company Profiles
Top Jobs
Genetown (Cambridge, Massachusetts)

Pfizer Inc.
Business Operations Manager
Support the Chief of Staff & Operations (CoSO) in the tracking and deployment of the budget to effectively deliver the objectives of the BioTx Research Units (RU) and Partner-Lines (PL). Facilitate alignment & commitment across RUs and Partner-Lines for value creation and execution on scientific and business strategy by developing and implementing effective communication from the leadership and across the RUs/PLs.

BioMidwest (Des Moines, Iowa)

Kemin Industries, Inc.
Sales Manager
Responsible for the direct sales of KAV products to the commercial companion animal industries (specifically through veterinarians), and assists with distribution management. Execution of short-and long-range domestic sales strategy, goals and objectives of company, as per budget strategies within assigned geographies.

Biotech Bay (Hercules, California)

Bio-Rad Laboratories, Inc.
Product Manager II
Responsible for marketing activities related to a line of autoimmune diagnostic products. Responsibilities include life-cycle management as well as support of international sales teams and marketing aspects of new product development including market research, definition of customer requirements, launch and training.

Pharm Country (Princeton, New Jersey)

Otsuka America Pharmaceutical, Inc.
Associate Manager Sales Training and Development
Assumes role of primary Neuroscience trainer and also assists with Specialty sales force for product training. Trains Neuroscience Specialists in product knowledge, marketplace competition, effective communication, basic to advanced selling and negotiation skills, business acumen, computer operations, administrative procedures, general medical terminology, managed care, and disease management.

BioCapital (Gaithersburg, Maryland)

MedImmune, LLC
Manager / Senior Manager Market Research
Influences the organization by strategically managing and providing information, intelligence and insights that drive critical business decisions. The Manager / Senior Manager leads the collection and interpretation of primary and secondary research and will provide strategic recommendations and insights on the direction of pipeline assets.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs

2012 Pharm Country Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Pharm Country Career Fair, Bridgewater, NJ September 13, 2012
Biotech Beach Career Fair, San Diego, CA September 20, 2012
Biotech Bay Career Fair, Burlingame, CA October 3, 2012
BioCapital Career Fair, Bethesda, MD October 9, 2012
BioMidwest Career Fair, Lincolnshire, IL October 22, 2012
Bio NC Career Fair, Durham, NC October 25, 2012
Genetown Career Fair, Cambridge, MA November 5, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


No comments: